CRISPR Therapeutics AG
NASDAQ:CRSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
Vistra Corp
NYSE:VST
|
US |
|
Outcrop Silver & Gold Corp
XTSX:OCG
|
CA |
|
Siemens Energy India Ltd
NSE:ENRIN
|
IN |
|
SAGE Therapeutics Inc
NASDAQ:SAGE
|
US |
|
Liquidia Corp
NASDAQ:LQDA
|
US |
|
CNH Industrial NV
MIL:CNHI
|
UK |
|
Ford Otomotiv Sanayi AS
IST:FROTO.E
|
TR |
|
Samsung Heavy Industries Co Ltd
KRX:010140
|
KR |
|
Daito Trust Construction Co Ltd
TSE:1878
|
JP |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
S
|
Salesforce Inc
XETRA:FOO
|
US |
|
Orca Gold Inc
XTSX:ORG
|
CA |
|
DFDS AS
OTC:DFDDF
|
DK |
|
Central Security Patrols Co Ltd
TSE:9740
|
JP |
|
Otto Energy Ltd
ASX:OEL
|
AU |
|
K
|
Kahoot ASA
XBER:KAH
|
NO |
|
Nick Scali Ltd
ASX:NCK
|
AU |
|
Sg Company SpA
MIL:SGC
|
IT |
|
Getty Realty Corp
NYSE:GTY
|
US |
|
H
|
Heidelberger Druckmaschinen AG
OTC:HBGRF
|
DE |
|
Netstreit Corp
NYSE:NTST
|
US |
|
Southern Petrochemical Industries Corporation Ltd
NSE:SPIC
|
IN |
|
E
|
Esi SpA
MIL:ESI
|
IT |
Bankruptcy Probability
CRISPR Therapeutics AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CRISPR Therapeutics AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
4.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CRISPR Therapeutics AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CRISPR Therapeutics AG has total debt of 585.5m USD. This includes both short-term (0 USD) and long-term (585.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
